LifeScan/Norvo Nordisk
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson diabetes care unit and Danish insulin producer will partner to develop devices focused on Type 1 or insulin-dependent patient populations, companies announce June 5. Financial details were not disclosed. The global market for glucose measuring products is projected to grow to about $4.7 bil. by 2002